Trial Profile

Phase II Clinical Trial of Pazopanib to evaluate the activity and tolerability in patients with advanced and/or metastatic liposarcoma who have relapsed following standard therapies or for whom no standard therapy exists

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 Jun 2019 Results (n=39) assessing tumor and plasma biomarkers that are differently expressed in long responders (LRs) PFS > 24 w, presented at the 55th Annual Meeting of the American Society of Clinical Oncology
31 Jul 2018 Status changed from active, no longer recruiting to completed.
22 Mar 2018 The study has been completed in Spain (End date: 2018-03-02)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com